Schreiner MediPharm, a global provider of functional label solutions for the healthcare industry, has developed Freeze-Lock, a cryo label that permanently withstands the sub-zero storage and transport temperatures needed for many cell and gene therapy medications or clinical trials – including those for COVID-19 mRNA vaccines.   The new solution contains two interlocking label layers that ensure reliable adhesive strength and product information readability. About Freeze-Lock Schreiner Me...